Please Wait...

DKK-1 // Dickkopf Related Protein-1

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Dickkopf family members are involved in the modulation of Wnt signaling. DKK1, the first member of this family (which comprises at least 4 cystein-rich protein), is an inhibitor of Wnt signaling. DKK1 has been found to not only promote bone resorption in a mouse model of arthritis but also to block bone formation and repair of diseased joint (Diarra et al., 2007). DKK1 appeared as a central player in bone homeostasis with implication in bone development and maintenance of bone mass as well as in formation of bone metastases (Pinzone et al., 2009).

Bioclinica Lab employs two manual immunoassays for the measurement of DKK1; one is dedicated to measurements in plasma EDTA and the second to measurements in serum.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

With many clinical trials slowed or terminated, investments in new technologies are difficult. Yet, a #CTMS with a… https://t.co/VRIhWWf4tE
Bioclinica (5 days ago)
With Bioclinica #CTMS, sponsors & CROs have access to a full-featured, scalable system - a single, centralized sour… https://t.co/7ACrv8cvuF
Bioclinica (1 week ago)
Now available: a DIY #EDC solution. From study start-up to close-out, Bioclinica EDC Solo is an efficient, cost-eff… https://t.co/vFhC7ITfZV
Bioclinica (2 weeks ago)
Reduce the number of user requirement iterations and UAT findings during the #IRT build process. With the agile app… https://t.co/TJt2sZlrFP
Bioclinica (2 weeks ago)
Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin… https://t.co/qIpi1MESXw
Bioclinica (3 weeks ago)
According to our recent poll, 45% of respondents had neither a #CTMS nor an #eTMF system, while only 24% had both.… https://t.co/l4dKC7pBQo
Bioclinica (3 weeks ago)